Solid Biosciences Inc (SLDB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2022 | 12-2021 | 09-2021 | 06-2021 | 03-2021 | |
| Sales | 1,925 | 3,154 | 3,537 | 3,594 | 3,335 |
| Gross Profit | 1,925 | 3,154 | 3,537 | 3,594 | 3,335 |
| Operating Expenses | 27,297 | 21,806 | 21,568 | 22,279 | 20,221 |
| Operating Income | -25,372 | -18,652 | -18,031 | -18,685 | -16,886 |
| Other Income | 44 | 42 | 48 | -10 | -14 |
| Pre-tax Income | -25,328 | -18,610 | -17,983 | -18,695 | -16,900 |
| Net Income Continuous | -25,328 | -18,610 | -17,983 | -18,695 | -16,900 |
| Net Income | $-25,328 | $-18,610 | $-17,983 | $-18,695 | $-16,900 |
| EPS Basic Total Ops | -3.37 | -2.34 | -2.40 | -2.55 | -2.85 |
| EPS Basic Continuous Ops | -3.37 | -2.41 | -2.40 | -2.50 | -2.84 |
| EPS Diluted Total Ops | -3.37 | -2.34 | -2.40 | -2.55 | -2.85 |
| EPS Diluted Continuous Ops | -3.37 | -2.41 | -2.40 | -2.50 | -2.84 |
| EBITDA(a) | $-24,292 | $-17,310 | $-16,752 | $-17,959 | $-16,152 |